NCT03240211 2025-08-26Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCLUniversity of VirginiaPhase 1 Active not recruiting37 enrolled
NCT02846935 2019-01-07p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid MalignanciesCase Comprehensive Cancer CenterPhase EARLY_PHASE1 Completed7 enrolled